Comparative Metabolism and Structure of BCKD-E2 in Primary Biliary Cirrhosis

J. M. Turchany, Patrick S Leung, T. Iwayama, D. M. Jefferson, J. Ishida, M. Yamaguchi, S. Munoz, D. J. Danner, E. Rolland Dickson, M. Eric Gershwin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The identification and cloning of the mitochondrial autoantigens in primary biliary cirrhosis (PBC) have provided new clues in disease pathogenesis. The two major autoantigens are the E2 subunits of pyruvate dehydrogenase and branched-chain ketoacid dehydrogenase (BCKD). Interestingly, one of these complexes, BCKD-E2, is already well known to clinical medicine based on its association with genetic mutations in maple syrup urine disease (MSUD). Patients with this disease have an inability to metabolize branched-chain amino acids. In the present study, we have taken advantage of the known sequence of BCKD-E2 from normal humans, and addressed the issue of whether there is an altered autoantigen sequence in hepatocytes of individuals with primary biliary cirrhosis. In particular, we examined both the leader sequence and the B-cell immunodominant epitope, the lipoic acid domain. In addition, because patients with PBC have autoantibodies to the BCKD-E2 complex, we have quantitated plasma levels of α-ketoacids potentially affected in maple syrup urine disease. These include pyruvic acid (PY), phenylpyruvic acid (PP), α-ketoisocaproic acid (KIC) α-ketoisovalerate (KIV) and α-keto-β-methylvaleric acid (KMV). The levels of these α-ketoacids were compared in patients with primary sclerosing cholangitis and normal volunteers. The sequence of BCKD-E2 obtained from PBC hepatocytes showed homology with normal BCKD. Further studies of autoantigen structure and sequence are clearly indicated, including those involved in mitochondrial transport and localization. Finally, we noted a statistically significant increase in all plasma α-ketoacids except α-keto-β-methylvaleric acid in PBC patients. The significance of this is unknown, but suggests that abnormalities in amino acid metabolism are secondary, not only to hepatic failure, but potentially to autoantibodies.

Original languageEnglish (US)
Pages (from-to)459-466
Number of pages8
JournalJournal of Autoimmunity
Volume6
Issue number4
DOIs
StatePublished - Aug 1993

Fingerprint

3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
Biliary Liver Cirrhosis
Autoantigens
Maple Syrup Urine Disease
Keto Acids
Pyruvic Acid
Autoantibodies
Hepatocytes
Imino Acids
B-Lymphocyte Epitopes
Thioctic Acid
Immunodominant Epitopes
Branched Chain Amino Acids
Sclerosing Cholangitis
Clinical Medicine
Liver Failure
Organism Cloning
Healthy Volunteers
Oxidoreductases
Mutation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Comparative Metabolism and Structure of BCKD-E2 in Primary Biliary Cirrhosis. / Turchany, J. M.; Leung, Patrick S; Iwayama, T.; Jefferson, D. M.; Ishida, J.; Yamaguchi, M.; Munoz, S.; Danner, D. J.; Dickson, E. Rolland; Gershwin, M. Eric.

In: Journal of Autoimmunity, Vol. 6, No. 4, 08.1993, p. 459-466.

Research output: Contribution to journalArticle

Turchany, JM, Leung, PS, Iwayama, T, Jefferson, DM, Ishida, J, Yamaguchi, M, Munoz, S, Danner, DJ, Dickson, ER & Gershwin, ME 1993, 'Comparative Metabolism and Structure of BCKD-E2 in Primary Biliary Cirrhosis', Journal of Autoimmunity, vol. 6, no. 4, pp. 459-466. https://doi.org/10.1006/jaut.1993.1038
Turchany, J. M. ; Leung, Patrick S ; Iwayama, T. ; Jefferson, D. M. ; Ishida, J. ; Yamaguchi, M. ; Munoz, S. ; Danner, D. J. ; Dickson, E. Rolland ; Gershwin, M. Eric. / Comparative Metabolism and Structure of BCKD-E2 in Primary Biliary Cirrhosis. In: Journal of Autoimmunity. 1993 ; Vol. 6, No. 4. pp. 459-466.
@article{497ca889ee7f41e1a3d9b0c04f7f8540,
title = "Comparative Metabolism and Structure of BCKD-E2 in Primary Biliary Cirrhosis",
abstract = "The identification and cloning of the mitochondrial autoantigens in primary biliary cirrhosis (PBC) have provided new clues in disease pathogenesis. The two major autoantigens are the E2 subunits of pyruvate dehydrogenase and branched-chain ketoacid dehydrogenase (BCKD). Interestingly, one of these complexes, BCKD-E2, is already well known to clinical medicine based on its association with genetic mutations in maple syrup urine disease (MSUD). Patients with this disease have an inability to metabolize branched-chain amino acids. In the present study, we have taken advantage of the known sequence of BCKD-E2 from normal humans, and addressed the issue of whether there is an altered autoantigen sequence in hepatocytes of individuals with primary biliary cirrhosis. In particular, we examined both the leader sequence and the B-cell immunodominant epitope, the lipoic acid domain. In addition, because patients with PBC have autoantibodies to the BCKD-E2 complex, we have quantitated plasma levels of α-ketoacids potentially affected in maple syrup urine disease. These include pyruvic acid (PY), phenylpyruvic acid (PP), α-ketoisocaproic acid (KIC) α-ketoisovalerate (KIV) and α-keto-β-methylvaleric acid (KMV). The levels of these α-ketoacids were compared in patients with primary sclerosing cholangitis and normal volunteers. The sequence of BCKD-E2 obtained from PBC hepatocytes showed homology with normal BCKD. Further studies of autoantigen structure and sequence are clearly indicated, including those involved in mitochondrial transport and localization. Finally, we noted a statistically significant increase in all plasma α-ketoacids except α-keto-β-methylvaleric acid in PBC patients. The significance of this is unknown, but suggests that abnormalities in amino acid metabolism are secondary, not only to hepatic failure, but potentially to autoantibodies.",
author = "Turchany, {J. M.} and Leung, {Patrick S} and T. Iwayama and Jefferson, {D. M.} and J. Ishida and M. Yamaguchi and S. Munoz and Danner, {D. J.} and Dickson, {E. Rolland} and Gershwin, {M. Eric}",
year = "1993",
month = "8",
doi = "10.1006/jaut.1993.1038",
language = "English (US)",
volume = "6",
pages = "459--466",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Comparative Metabolism and Structure of BCKD-E2 in Primary Biliary Cirrhosis

AU - Turchany, J. M.

AU - Leung, Patrick S

AU - Iwayama, T.

AU - Jefferson, D. M.

AU - Ishida, J.

AU - Yamaguchi, M.

AU - Munoz, S.

AU - Danner, D. J.

AU - Dickson, E. Rolland

AU - Gershwin, M. Eric

PY - 1993/8

Y1 - 1993/8

N2 - The identification and cloning of the mitochondrial autoantigens in primary biliary cirrhosis (PBC) have provided new clues in disease pathogenesis. The two major autoantigens are the E2 subunits of pyruvate dehydrogenase and branched-chain ketoacid dehydrogenase (BCKD). Interestingly, one of these complexes, BCKD-E2, is already well known to clinical medicine based on its association with genetic mutations in maple syrup urine disease (MSUD). Patients with this disease have an inability to metabolize branched-chain amino acids. In the present study, we have taken advantage of the known sequence of BCKD-E2 from normal humans, and addressed the issue of whether there is an altered autoantigen sequence in hepatocytes of individuals with primary biliary cirrhosis. In particular, we examined both the leader sequence and the B-cell immunodominant epitope, the lipoic acid domain. In addition, because patients with PBC have autoantibodies to the BCKD-E2 complex, we have quantitated plasma levels of α-ketoacids potentially affected in maple syrup urine disease. These include pyruvic acid (PY), phenylpyruvic acid (PP), α-ketoisocaproic acid (KIC) α-ketoisovalerate (KIV) and α-keto-β-methylvaleric acid (KMV). The levels of these α-ketoacids were compared in patients with primary sclerosing cholangitis and normal volunteers. The sequence of BCKD-E2 obtained from PBC hepatocytes showed homology with normal BCKD. Further studies of autoantigen structure and sequence are clearly indicated, including those involved in mitochondrial transport and localization. Finally, we noted a statistically significant increase in all plasma α-ketoacids except α-keto-β-methylvaleric acid in PBC patients. The significance of this is unknown, but suggests that abnormalities in amino acid metabolism are secondary, not only to hepatic failure, but potentially to autoantibodies.

AB - The identification and cloning of the mitochondrial autoantigens in primary biliary cirrhosis (PBC) have provided new clues in disease pathogenesis. The two major autoantigens are the E2 subunits of pyruvate dehydrogenase and branched-chain ketoacid dehydrogenase (BCKD). Interestingly, one of these complexes, BCKD-E2, is already well known to clinical medicine based on its association with genetic mutations in maple syrup urine disease (MSUD). Patients with this disease have an inability to metabolize branched-chain amino acids. In the present study, we have taken advantage of the known sequence of BCKD-E2 from normal humans, and addressed the issue of whether there is an altered autoantigen sequence in hepatocytes of individuals with primary biliary cirrhosis. In particular, we examined both the leader sequence and the B-cell immunodominant epitope, the lipoic acid domain. In addition, because patients with PBC have autoantibodies to the BCKD-E2 complex, we have quantitated plasma levels of α-ketoacids potentially affected in maple syrup urine disease. These include pyruvic acid (PY), phenylpyruvic acid (PP), α-ketoisocaproic acid (KIC) α-ketoisovalerate (KIV) and α-keto-β-methylvaleric acid (KMV). The levels of these α-ketoacids were compared in patients with primary sclerosing cholangitis and normal volunteers. The sequence of BCKD-E2 obtained from PBC hepatocytes showed homology with normal BCKD. Further studies of autoantigen structure and sequence are clearly indicated, including those involved in mitochondrial transport and localization. Finally, we noted a statistically significant increase in all plasma α-ketoacids except α-keto-β-methylvaleric acid in PBC patients. The significance of this is unknown, but suggests that abnormalities in amino acid metabolism are secondary, not only to hepatic failure, but potentially to autoantibodies.

UR - http://www.scopus.com/inward/record.url?scp=0027301912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027301912&partnerID=8YFLogxK

U2 - 10.1006/jaut.1993.1038

DO - 10.1006/jaut.1993.1038

M3 - Article

VL - 6

SP - 459

EP - 466

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 4

ER -